Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials
Ginecologia e ObstetríciaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Journal of the National Cancer Institute
- Publicado em
- 28 jan 2017
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials
Joseph E Tota, Frank Struyf, Marko Merikukka, Paula Gonzalez, Aimée R Kreimer, Dan Bi, Xavier Castellsagué, Newton S de Carvalho, Suzanne M Garland, Diane M Harper et al.
Descritores MeSH
- Uterine Cervical Dysplasia
- Papillomavirus Infections
- Human papillomavirus 18
- Human papillomavirus 16
- Papillomavirus Vaccines
- Uterine Cervical Neoplasms
- Humans
- Vaccination
- Treatment Outcome
- Adolescent
Veja também
Estudos relacionados
- Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial
- Maximizing impact: the power of early HPV vaccination for long-term protection-lessons from a systematic review and meta-regression analysis
- Effects of different-valent vaccines against human papillomavirus (HPV) to prevent persistent HPV16/18 infections and CIN2+ in women: a systematic review and network meta-analysis
- Variations in the Natural History of High-Risk HPV Types Following HPV-16/18 Bivalent Vaccination in Females Aged 18-45 Years